Evidence is insufficient in assessing the benefits and harms of doxy PEP in cisgender women cisgender heterosexual men transgender men and other queer and nonbinary persons

Evidence is insufficient in assessing the benefits and harms of doxy PEP in cisgender women, cisgender heterosexual men, transgender men, and other queer and nonbinary persons.